HRP20020730A2 - A process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities - Google Patents
A process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities Download PDFInfo
- Publication number
- HRP20020730A2 HRP20020730A2 HRP20020730A HRP20020730A2 HR P20020730 A2 HRP20020730 A2 HR P20020730A2 HR P20020730 A HRP20020730 A HR P20020730A HR P20020730 A2 HRP20020730 A2 HR P20020730A2
- Authority
- HR
- Croatia
- Prior art keywords
- lovastatin
- simvastatin
- mixtures
- solvent
- mixture
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pyrane Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18686800P | 2000-03-03 | 2000-03-03 | |
| PCT/US2001/006334 WO2001066538A1 (en) | 2000-03-03 | 2001-02-27 | A process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20020730A2 true HRP20020730A2 (en) | 2004-12-31 |
Family
ID=22686591
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20020730 HRP20020730A2 (en) | 2000-03-03 | 2001-02-27 | A process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6521762B2 (cs) |
| EP (1) | EP1265884A4 (cs) |
| JP (1) | JP2003525935A (cs) |
| KR (1) | KR20030069790A (cs) |
| CN (1) | CN1443182A (cs) |
| AU (1) | AU4183301A (cs) |
| CA (1) | CA2402061A1 (cs) |
| CZ (1) | CZ20023201A3 (cs) |
| DE (1) | DE01913139T1 (cs) |
| HR (1) | HRP20020730A2 (cs) |
| HU (1) | HUP0301214A2 (cs) |
| IL (1) | IL151583A0 (cs) |
| IS (1) | IS6533A (cs) |
| PL (1) | PL357533A1 (cs) |
| SK (1) | SK13782002A3 (cs) |
| TR (1) | TR200403001T3 (cs) |
| WO (1) | WO2001066538A1 (cs) |
| ZA (1) | ZA200207023B (cs) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100435078B1 (ko) * | 2002-02-08 | 2004-06-09 | 종근당바이오 주식회사 | 심바스타틴의 정제방법 |
| WO2005054253A1 (en) * | 2003-12-05 | 2005-06-16 | Biocon Limited | Process for the purification of macrolides |
| US7199126B2 (en) * | 2004-04-29 | 2007-04-03 | Pharmix Corporation | Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase |
| US7183285B2 (en) * | 2004-04-29 | 2007-02-27 | Pharmix Corp. | Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase |
| US20050272770A1 (en) * | 2004-04-29 | 2005-12-08 | John Griffin | Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase |
| US20050282883A1 (en) * | 2004-04-29 | 2005-12-22 | John Griffin | Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase |
| US8012498B2 (en) | 2004-07-12 | 2011-09-06 | Sandhya Goyal | Topical gel formulation comprising organophosphate insecticide and preparation thereof |
| US8158139B2 (en) * | 2004-07-12 | 2012-04-17 | Taro Pharmaceuticals North America, Inc. | Topical gel formulation comprising organophosphate insecticide and preparation thereof |
| US20070015779A1 (en) * | 2005-04-29 | 2007-01-18 | John Griffin | Compositions and treatments for inhibiting kinase and/or hmg-coa reductase |
| US7560445B2 (en) | 2005-07-06 | 2009-07-14 | Taro Pharmaceuticals North America, Inc. | Process for preparing malathion for pharmaceutical use |
| WO2007061849A2 (en) * | 2005-11-23 | 2007-05-31 | Merck & Co., Inc. | Method of generating amorphous solid for water-insoluble pharmaceuticals |
| WO2008147807A2 (en) | 2007-05-23 | 2008-12-04 | Amcol International Corporation | Cholesterol-interacting layered phyllosilicates and methods of reducing hypercholesteremia in a mammal |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5925599B2 (ja) | 1979-02-20 | 1984-06-19 | 三共株式会社 | 新生理活性物質モナコリンｋおよびその製造法 |
| US4319039A (en) * | 1979-06-15 | 1982-03-09 | Merck & Co., Inc. | Preparation of ammonium salt of hypocholesteremic fermentation product |
| US4294926A (en) | 1979-06-15 | 1981-10-13 | Merck & Co., Inc. | Hypocholesteremic fermentation products and process of preparation |
| US4294846A (en) | 1979-09-21 | 1981-10-13 | Merck & Co., Inc. | Hypocholesteremic fermentation products and products of preparation |
| US4342767A (en) | 1980-01-23 | 1982-08-03 | Merck & Co., Inc. | Hypocholesteremic fermentation products |
| US4444784A (en) | 1980-08-05 | 1984-04-24 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
| US4420491A (en) | 1980-05-28 | 1983-12-13 | Merck & Co., Inc. | Hypocholesteremic fermentation products and process of preparation |
| US4582915A (en) | 1983-10-11 | 1986-04-15 | Merck & Co., Inc. | Process for C-methylation of 2-methylbutyrates |
| US4820850A (en) | 1987-07-10 | 1989-04-11 | Merck & Co., Inc. | Process for α-C-alkylation of the 8-acyl group on mevinolin and analogs thereof |
| US4916239A (en) | 1988-07-19 | 1990-04-10 | Merck & Co., Inc. | Process for the lactonization of mevinic acids and analogs thereof |
| US5202029A (en) * | 1991-03-13 | 1993-04-13 | Caron Kabushiki Kaisha | Process for purification of hmg-coa reductase inhibitors |
| HU210867B (en) * | 1992-11-04 | 1995-10-30 | Biogal Gyogyszergyar | Method for extraction and purification of mevinolin from culture medium |
| SI9300047A (en) | 1993-01-29 | 1994-09-30 | Krka | Microbiological method for preparation of lovostatin and/or mevinoline acid |
| US5409820A (en) | 1993-08-06 | 1995-04-25 | Apotex, Inc. | Process for the production of lovastatin using Coniothyrium fuckelii |
| UA44922C2 (uk) * | 1995-12-06 | 2002-03-15 | Балканфарма-Разград Ад | Спосіб одержання ловастатину |
| IN186880B (cs) | 1997-10-28 | 2001-12-01 | Ranbaxy Lab Ltd | |
| IN186879B (cs) | 1997-10-28 | 2001-12-01 | Ranbaxy Lab Ltd | |
| SI9800046A (sl) | 1998-02-18 | 1999-08-31 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze visoke čistosti |
| SI20072A (sl) * | 1998-09-18 | 2000-04-30 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze |
| US6380401B1 (en) | 1999-10-27 | 2002-04-30 | Merck & Co., Inc. | Lactonization process |
-
2001
- 2001-02-27 TR TR2004/03001T patent/TR200403001T3/xx unknown
- 2001-02-27 US US09/793,946 patent/US6521762B2/en not_active Expired - Fee Related
- 2001-02-27 CN CN01808689A patent/CN1443182A/zh active Pending
- 2001-02-27 CZ CZ20023201A patent/CZ20023201A3/cs unknown
- 2001-02-27 IL IL15158301A patent/IL151583A0/xx unknown
- 2001-02-27 DE DE01913139T patent/DE01913139T1/de active Pending
- 2001-02-27 SK SK1378-2002A patent/SK13782002A3/sk not_active Application Discontinuation
- 2001-02-27 EP EP01913139A patent/EP1265884A4/en not_active Withdrawn
- 2001-02-27 PL PL01357533A patent/PL357533A1/xx not_active Application Discontinuation
- 2001-02-27 CA CA002402061A patent/CA2402061A1/en not_active Abandoned
- 2001-02-27 KR KR1020027011541A patent/KR20030069790A/ko not_active Withdrawn
- 2001-02-27 JP JP2001565354A patent/JP2003525935A/ja active Pending
- 2001-02-27 AU AU4183301A patent/AU4183301A/xx active Pending
- 2001-02-27 HR HRP20020730 patent/HRP20020730A2/hr not_active Application Discontinuation
- 2001-02-27 WO PCT/US2001/006334 patent/WO2001066538A1/en not_active Ceased
- 2001-02-27 HU HU0301214A patent/HUP0301214A2/hu unknown
-
2002
- 2002-08-29 IS IS6533A patent/IS6533A/is unknown
- 2002-09-02 ZA ZA200207023A patent/ZA200207023B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK13782002A3 (sk) | 2004-02-03 |
| US20020002288A1 (en) | 2002-01-03 |
| HUP0301214A2 (hu) | 2003-08-28 |
| AU4183301A (en) | 2001-09-17 |
| WO2001066538A1 (en) | 2001-09-13 |
| CN1443182A (zh) | 2003-09-17 |
| IS6533A (is) | 2002-08-29 |
| US6521762B2 (en) | 2003-02-18 |
| EP1265884A1 (en) | 2002-12-18 |
| KR20030069790A (ko) | 2003-08-27 |
| JP2003525935A (ja) | 2003-09-02 |
| EP1265884A4 (en) | 2003-05-21 |
| PL357533A1 (en) | 2004-07-26 |
| TR200403001T3 (tr) | 2005-02-21 |
| ZA200207023B (en) | 2003-09-02 |
| CA2402061A1 (en) | 2001-09-13 |
| CZ20023201A3 (cs) | 2003-09-17 |
| IL151583A0 (en) | 2003-04-10 |
| DE01913139T1 (de) | 2005-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100699368B1 (ko) | 신규한 ＨＭＧ-ＣｏＡ 환원효소 억제제 염 | |
| ES2178093T5 (es) | Derivados de epotilon y su preparacion. | |
| US4294846A (en) | Hypocholesteremic fermentation products and products of preparation | |
| SK148095A3 (en) | Process for the isolation of lovastin | |
| HRP20020730A2 (en) | A process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities | |
| IE53740B1 (en) | Mb-530b derivatives, their preparation and pharmaceutical compositions containing them | |
| HRP20020683A2 (en) | Method of purifying a fermentation broth | |
| US4420491A (en) | Hypocholesteremic fermentation products and process of preparation | |
| EP0705256B1 (en) | Process for the preparation of n-acetyl neuraminic acid derivatives | |
| US7323592B2 (en) | Methods for crystallization of hydroxycarboxylic acids | |
| AU2001241833A2 (en) | A process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities | |
| US7566792B2 (en) | Method for the manufacture of Lovastatin | |
| US20030204105A1 (en) | Method for purification of pravastatin or a pharmacologically acceptable salt thereof | |
| MXPA02005893A (es) | Proceso para la preparacion de sales de sodio de estatinas. | |
| HK1011995B (en) | Process for the preparation of n-acetyl neuraminic acid derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20030304 Year of fee payment: 3 |
|
| A1OB | Publication of a patent application | ||
| OBST | Application withdrawn |